Lv12
60 积分 2025-05-16 加入
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity
7小时前
待审核
A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy
7小时前
待审核
Recovery from parenteral nutrition‐associated cholestasis takes approximately two months in very low birth weight infants
皖公网安备34019202002308
